期刊文献+

不同抗癫痫药在脑炎继发癫痫治疗中的安全性及效果分析 被引量:11

The Safety and Effectiveness Analysis of Different Antiepileptic Drugs in the Treatment of Secondary Epilepsy After Viral Encephalitis
下载PDF
导出
摘要 目的对卡马西平、托吡酯以及丙戊酸钠缓释片三种抗癫痫药用于脑炎继发癫痫中的疗效进行分析。方法将本院进行治疗的脑炎继发癫痫患者150例,随机将其分为A、B、C三组各50例,A组给予马西平进行治疗,B组给予托吡酯进行治疗,C组给予丙戊酸钠缓释片进行治疗,比较三组患者的临床治疗效果以及不良反应发生情况。结果三组相比,总有效率差异不显著(P>0.05);不良反应比较差异显著(P<0.05)。结论卡马西平、托吡酯以及丙戊酸钠缓释片治疗脑炎继发癫痫的效果相当,但托吡酯的不良反应率较低,更具有安全性。 Objective To analyze and investigate the safety and effectiveness of different antiepileptic drugs in the treatment of secondary epilepsy after viral encephalitis. Methods The hospital for treatment of 150 cases of secondary epilepsy after viral encephalitis patients, randomly divided into A, B, C three groups with 50 cases in each group, group A was given the carbamazepine treatment, group B was treated with topiramate for treatment, group C was treated with sodium valproate sustained release tablets for treatment, to compare the occurrence of three groups of patients with clinical curative effect and adverse reaction. Results The total efficiency of three groups compared, the difference was not significant(P〈0.05), adverse reactions are significantly different(P〈0.05). Conclusion Carbamazepine, topiramate and sodium valproate sustained release tablets in the treatment of epilepsy secondary to encephalitis effect, but the adverse effects of topiramate rate is low, so it has more security.
作者 胡奇华
出处 《中国继续医学教育》 2015年第15期120-121,共2页 China Continuing Medical Education
关键词 癫痫 卡马西平 托吡酯 丙戊酸钠缓释片 Epilepsy Carbamazepine Topiramate Sodium valproate
  • 相关文献

参考文献2

二级参考文献16

  • 1梁宪光,陈亮,范晓芳.急诊不同年龄强直阵挛性发作性癫痫的病因分析[J].临床荟萃,2005,20(13):764-765. 被引量:2
  • 2陈彩云.病毒性脑炎急性期继发癫62例临床分析[J].中国煤炭工业医学杂志,2005,8(10):1129-1130. 被引量:1
  • 3张玉琴,张培元,刘丽珍.儿童病毒性脑炎继发癫癎危险因素及预后分析[J].天津医药,2007,35(3):182-184. 被引量:10
  • 4陈显光,何文贞,徐巧玉.妥泰治疗病毒性脑炎继发癫痫的临床观察(附1例报告)[J].实用中西医结合临床,2007,7(3):5-6. 被引量:4
  • 5Usha KM,Chong T,Jayantee K.Viral encephalitis and epilepsy[J].Epilepsia,2008,49 Suppl 6:S13.
  • 6Kim JM,Kwon S,Seo HE,et al.Long-term effectiveness and tolerability of topiramate in children with epilepsy under the age of 2 years:4-year follow-up[J].J Korean Med Sci,2009,24(6):1078.
  • 7Zaccara G,Messori A,Cincotta M,et al.Comparison of the efficacy and tolerability of new antiepileptic drugs:what can we learn from long-term studies?[J].Acta Neurol Scand,2006,114:157.
  • 8Faught E.Topiramate in the treatment of partial and generalized epilepsy[J].Neuropsychiatr Dis Treat,2007,3(6):811.
  • 9Kurth C,Sch(a)uble B,Schreiner A,et al.Exploring efficacy and tolerability outcomes in patients with difficult-to-treat epilepsy receiving adjunctive topiramate at different titration rates--an exploratory study[J].Acta Neurol Scand,2009,120(2):80.
  • 10Bootsma HP,Ricker L,Diepman L,et al.Long-term effects of levetiracetam and topiramate in clinical practice:A head-to-head comparison[J].Seizure,2008,17:31.

共引文献57

同被引文献71

引证文献11

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部